|
|
|
Volumn 28, Issue 10 Suppl, 2005, Pages 14-22
|
|
Circulating osteoprotegerin and soluble RANKL: do they have a future in clinical practice?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
CARRIER PROTEIN;
CELL RECEPTOR;
GLYCOPROTEIN;
MEMBRANE PROTEIN;
OSTEOCLAST DIFFERENTIATION FACTOR;
OSTEOPROTEGERIN;
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;
TNFRSF11A PROTEIN, HUMAN;
TNFRSF11B PROTEIN, HUMAN;
TNFSF11 PROTEIN, HUMAN;
TUMOR NECROSIS FACTOR RECEPTOR;
BLOOD;
BONE;
BONE TUMOR;
CARDIOVASCULAR DISEASE;
COHORT ANALYSIS;
HUMAN;
METABOLIC BONE DISEASE;
MULTIPLE MYELOMA;
PATHOLOGY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
REVIEW;
RISK FACTOR;
SIGNAL TRANSDUCTION;
BIOLOGICAL MARKERS;
BONE AND BONES;
BONE DISEASES, METABOLIC;
BONE NEOPLASMS;
CARDIOVASCULAR DISEASES;
CARRIER PROTEINS;
COHORT STUDIES;
GLYCOPROTEINS;
HUMANS;
MEMBRANE GLYCOPROTEINS;
MULTIPLE MYELOMA;
OSTEOPROTEGERIN;
RANK LIGAND;
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
RECEPTORS, TUMOR NECROSIS FACTOR;
RISK FACTORS;
SIGNAL TRANSDUCTION;
|
|
EID: 33645820419
PISSN: 03914097
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (30)
|
|
References (96)
|
